SEC Form 4 · accession 0001477932-18-002972
Nascent Biotech Inc. · NBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Douglas John Karas
Director
Period of report
Apr 3, 2015
Accepted (ET)
Jun 11, 2018 · 11:31 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001622057
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 3, 2015 | P | 10,000 | $1.00 | A | 10,000 | D | |
| Common Stock | Aug 14, 2017 | J | 50,000 | $0.22 | A | 60,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares were granted as part of the employment contract with the Company.